Provider review
Ro
Direct-to-consumer GLP-1 program with broad medication selection and a polished app.
Provider review
Direct-to-consumer GLP-1 program with broad medication selection and a polished app.
Rating breakdown
Editorial scores out of 5 — see our scoring rubric for the criteria behind each axis.
Who's behind this provider
Source: ro.co/about + Crunchbase. Last verified 2026-04-12. Funding figures are cumulative disclosed raises; private-company numbers may lag the live cap table by 1 round.
We earn a commission if you sign up through this link. Editorial ranking is independent.
Verified user experiences. Reviews are moderated before publishing — we strip personal info and reject spam.
Was this page helpful?
Be the first to share your experience — consults, shipping, billing, support. The form below takes ~2 minutes.